SCHEMBL5752237

SCHEMBL5752237

CCOC(=O)c1cccc2c([N+](=O)[O-])cccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
GAA P10253 1/20 0.54
TDP1 Q9NUW8 1/20 0.53
TSHR P16473 2/20 0.53
LMNA P02545 2/20 0.52
POLB P06746 2/20 0.52
GALR2 O43603 1/20 0.52
MITF O75030 1/20 0.52
HSP90AA1 P07900 1/20 0.52
HPGD P15428 1/20 0.52
XBP1 P17861 1/20 0.52
CCR6 P51684 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MAPT P10636 5/20 0.51
CDC25B P30305 2/20 0.50
KMT2A Q03164 2/20 0.47
CLEC4M Q9H2X3 1/20 0.47
CDC25A P30304 1/20 0.47
CDC25C P30307 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11329048 0.86 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2GAATDP1TSHR
SCHEMBL3481205 0.85 TSHR (0.64) ALDH1A1SMN1; SMN2GAATDP1TSHR
SCHEMBL1523174 0.84 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2GAATSHRLMNA
SCHEMBL9150759 0.84 TSHR (0.73) ALDH1A1TSHRMAPTCDC25BKMT2A
SCHEMBL1611630 0.84 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2GAATSHRLMNA
SCHEMBL11464655 0.84 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2GAATDP1TSHR
SCHEMBL8416055 0.83 TDP1 (0.58) ALDH1A1SMN1; SMN2TDP1TSHRLMNA
SCHEMBL4958070 0.83 TDP1 (0.62) ALDH1A1SMN1; SMN2GAATDP1TSHR
SCHEMBL11328251 0.82 TSHR (0.50) ALDH1A1SMN1; SMN2GAATDP1TSHR
SCHEMBL2977262 0.82 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2GAATSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed
CN-1437587-A Benzoxazepinones and their use as squalene synthetase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-08-20 CN disclosed
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-04-24 US disclosed
EP-1292585-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-03-19 EP disclosed
WO-2001098282-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 2001-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP ALDH1A1 783/4885SMN1; SMN2 4771/4885GAA 3065/4885
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors SQLE, CYP17A1, ACOX1 ALDH1A1 1026/4885SMN1; SMN2 4321/4885GAA 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.